FFRangio System vs cV4 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

FFRangio System

by CathWorks (acquired by Medtronic)

cV4 Diagnostic Ultrasound System

by Samsung Medison

AI Verdict

Tool A is a highly specialized system designed for functional assessment of coronary artery disease, providing FFR guidance to optimize PCI decisions. In contrast, Tool B is a multi-specialty diagnostic ultrasound system that utilizes AI for enhanced imaging and automated measurements across diverse clinical applications, including some cardiac assessments. While both leverage AI in cardiology, they address distinct clinical problems and employ different core technologies.

Choose FFRangio System if…

Choose the FFRangio System if your cardiology practice requires precise, wire-free functional assessment of coronary artery disease to optimize percutaneous coronary intervention (PCI) decisions. This system is ideal for interventional cardiologists seeking real-time FFR guidance, simulated pullback curves, and lesion impact analysis without the need for invasive pressure wires or vasoactive drugs. It streamlines the diagnostic and treatment planning process by integrating seamlessly with existing cath lab equipment.

View FFRangio System →

Choose cV4 Diagnostic Ultrasound System if…

Choose the cV4 Diagnostic Ultrasound System if your clinic or hospital needs a versatile, AI-enabled diagnostic imaging solution for a broad range of specialties, including OB/GYN, cardiology, and radiology. This system excels in providing enhanced image quality and automated measurements through features like HeartAssist and BiometryAssist, significantly streamlining workflows for various diagnostic assessments. It is particularly well-suited for environments prioritizing robust data security and a silent, fanless operation for patient comfort and device longevity.

View cV4 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	FFRangio System	cV4 Diagnostic Ultrasound System
Pricing	Contact vendor for pricing information.	Unknown
Deployment	SaaS, on-prem, hybrid	On-premise
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cV4 Diagnostic Ultrasound System

Tool B, the cV4 Diagnostic Ultrasound System, offers multiple AI-powered assists (HeartAssist, NerveTrack, BiometryAssist, LaborAssist) that directly automate complex measurements and detections, significantly streamlining workflows and reducing manual effort for clinicians. Additionally, its fanless design contributes to a quieter and more comfortable working environment, enhancing the overall user experience.

Clinical Value

FFRangio System

The FFRangio System (Tool A) provides wire-free and drug-free 3D FFR guidance, offering a transformative, non-invasive alternative to a traditionally invasive procedure for assessing coronary artery disease. It delivers real-time, comprehensive physiological data crucial for optimizing PCI decisions, directly impacting critical treatment pathways by reducing patient risk and improving efficiency.

Pricing & Value

Tie

Both tools require direct contact for pricing, and neither provides sufficient public information to assess their cost-effectiveness or overall value proposition. Without specific pricing details or comparative cost-benefit analyses, a definitive winner cannot be determined on this dimension.

Enterprise Readiness

cV4 Diagnostic Ultrasound System

The cV4 Diagnostic Ultrasound System (Tool B) explicitly states HIPAA compliance and details robust cybersecurity features, including SSD encryption, DICOM TLS for transmission, and audit trails, which are critical for secure PHI handling in an enterprise environment. Its DICOM 3.0 compatibility further ensures seamless integration into existing hospital imaging workflows.

Innovation

FFRangio System

The FFRangio System (Tool A) stands out for its core innovation of providing wire-free and drug-free 3D FFR guidance, representing a significant paradigm shift in cardiac diagnostics. This offers a less invasive yet highly informative approach to coronary physiology, directly addressing a critical clinical need with a novel methodology.

Support & Docs

Tie

Neither the provided structured facts nor general web searches offer specific comparative details regarding the quality, accessibility, or comprehensiveness of support and documentation for either product. While both companies likely offer standard corporate support, there is insufficient information to distinguish between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	FFRangio System	cV4 Diagnostic Ultrasound System
Name	FFRangio System	cV4 Diagnostic Ultrasound System
Company	CathWorks	Samsung Medison Co.
Primary Function	Delivers wire-free and drug-free 3D FFR guidance for optimizing PCI decisions in coronary artery disease.	AI-enabled, fanless diagnostic ultrasound system offering advanced imaging, streamlined workflows, and robust data security for diverse clinical applications.
Key Specialties	Cardiology	Maternal-Fetal Medicine, Obstetrics & Gynecology, Radiology
Core AI-powered Feature	Artificial intelligence aids in quick angiogram analysis; Real-time FFRangio values at every point on the coronary tree	AI-powered HeartAssistu2122 for automated fetal heart assessment; AI-powered NerveTracku2122 for real-time nerve detection
Unique Technology/Benefit	Eliminates the need for invasive pressure wires, drugs, or a guide catheter; Wire-free and drug-free 3D FFR guidance.	World's first fanless design for silent operation and extended lifespan; Crystal Architectureu2122 for enhanced image quality.

Videos

Demos, reviews, and walkthroughs featuring FFRangio System and cV4 Diagnostic Ultrasound System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and target specialties for the FFRangio System versus the cV4 Diagnostic Ultrasound System?

The FFRangio System is specifically designed for cardiology, providing wire-free and drug-free 3D FFR guidance to optimize PCI decisions for patients with coronary artery disease. In contrast, the cV4 Diagnostic Ultrasound System is an AI-enabled diagnostic ultrasound system offering advanced imaging for diverse clinical applications, primarily serving specialties like Maternal-Fetal Medicine, Obstetrics & Gynecology, and Radiology.

How do these tools leverage artificial intelligence to enhance clinical workflows or diagnostic accuracy?

The FFRangio System utilizes AI for quick angiogram analysis, generating real-time FFRangio values and advanced insights to optimize PCI decisions. The cV4 Diagnostic Ultrasound System incorporates AI-powered features such as HeartAssistu2122, NerveTracku2122, BiometryAssistu2122, and LaborAssistu2122 to automate fetal assessments and measurements, streamlining workflows in ultrasound diagnostics.

How do these systems differ in their approach to patient invasiveness or the need for pharmacological agents during diagnosis?

The FFRangio System eliminates the need for invasive pressure wires, drugs, or a guide catheter to obtain FFR results, offering a wire-free and drug-free approach to coronary physiology assessment. The cV4 Diagnostic Ultrasound System is a non-invasive diagnostic imaging tool that uses sound waves to generate real-time images and does not require invasive procedures or pharmacological agents for its operation.

What unique technological features does each system offer that could impact diagnostic confidence or operational efficiency?

The FFRangio System offers real-time FFRangio values at every point on the coronary tree, a simulated pullback curve to differentiate functional patterns of CAD, and a Lesion Impact feature to assess residual ischemia. The cV4 Diagnostic Ultrasound System features Crystal Architectureu2122 (CrystalBeamu2122 & CrystalLiveu2122) for enhanced image quality and is the world's first fanless design for silent operation and extended lifespan.